Chasing The Elusive Dream Of A COVID Cure
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
Drugs
621 - 640 of 1,292 Results
-
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Listen: A New Hope In The Battle Against COVID-19
KHN’s Julie Rovner joins a panel of journalists on “1A” to talk about promising results in a study of the drug remdesivir and other developments in the battle against the coronavirus.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN’s ‘What The Health?’: SCOTUS Decides An ACA Case. No, Not THAT Case.
The Supreme Court this week, in an 8-1 decision, ruled that insurers are due the roughly $12 billion that Congress several years ago tried to cut off in payments under the Affordable Care Act’s “risk corridors” provision. And while the COVID-19 pandemic continues to rage in many places around the country, states are starting to reopen their economies at the urging of President Donald Trump and over objections of public health officials. Caitlin Owens of Axios and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Carmen Heredia Rodriguez, who wrote the latest KHN-NPR “Bill of the Month” installment about COVID testing that should have been free but was not.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Amid Pandemic, FDA Seizes Cheaper Drugs From Canada
Many Americans order drugs from Canada and other countries because they are cheaper, but U.S. authorities appear to be cracking down on the practice.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN’s ‘What The Health?’: How Will We Reopen The Economy?
The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
-
With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’
The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.
-
‘You Pray That You Got The Drug.’ Ailing Couple Gambles On Trial For COVID-19 Cure
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Why Hoarding Of Hydroxychloroquine Needs To Stop
Six states — Idaho, Louisiana, Nevada, North Carolina, Ohio and Texas — have taken steps to limit inappropriate prescriptions for the medicine and preserve supplies for patients who take it for lupus and rheumatoid arthritis.
-
Senators Who Led Pharma-Friendly Patent Reform Also Prime Targets For Pharma Cash
Three senators on a revived subcommittee received more than $100,000 each from drugmakers.
-
Mask Shortage Straps Pharmacists Who Need Them To Keep Medicines Pure
Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically use or are using substitutes for masks.
-
Heart Association Puts Halt To Bayer’s Giant Displays Of Baby Aspirin
After Kaiser Health News’ questions, the association tells the aspirin maker to take down display bins at Walmart pharmacies that gave a false impression that the over-the-counter drug is recommended for everyone to prevent heart attacks.
-
Colorado Forges Ahead On A New Model For Health Care While Nation Waits
Since gaining control of the House, Senate and governor’s office, Colorado Democrats are pushing an aggressive health care agenda. With measures to create a public insurance option, welcome drug importation, lower drug prices, curtail surprise billing and cap insulin copays, the state is becoming a likely model for health policies at the federal level.
-
Letters to the Editor
Readers And Tweeters Dive Into Debate Over ‘Medicare For All’
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
As The Coronavirus Spreads, Americans Lose Ground Against Other Health Threats
Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.
By Liz Szabo